Beatrice Stefanie Ludwig

Journal of Medicinal Chemistry Cite this: J. Med. Chem. 2025, XXXX, XXX Click to copy citationCitation copied! . This publication is licensed under CC-BY 4.0 . You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters below: Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.

Journal of Medicinal Chemistry Cite this: J. Med. Chem. 2025, XXXX, XXX Click to copy citationCitation copied! . This publication is licensed under CC-BY 4.0 . You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters below: Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.

Nowadays, the clinical efficacy of chemotherapeutic drugs is frequently hampered either by a lack of selectivity over healthy cells or by poor pharmacokinetic properties, including cancer homing and penetration.